High Tide Inc Is Maintained at Outperform by ATB Capital
High Tide Inc Price Target Is Maintained at C$6.50/Share by ATB Capital
High Tide Analyst Ratings
CCORF Maintains High Tide(HITI.US) With Buy Rating, Raises Target Price to $3.3
Roth MKM Maintains High Tide(HITI.US) With Buy Rating, Maintains Target Price $4.5
High Tide (HITI) Gets a Buy From Roth MKM
Canaccord Genuity Maintains Buy on High Tide, Raises Price Target to C$4.5
High Tide Analyst Ratings
Analysts Offer Insights on Healthcare Companies: High Tide (HITI), Venus Concept (VERO) and Immunocore Holdings (IMCR)
High Tide Analyst Ratings
High Tide's Resilient Performance and Strategic Growth Merit Buy Rating
High Tide's Strong Financials and Strategic Growth Initiatives Merit a Buy Rating
High Tide Maintained at Buy at Stifel GMP as Fiscal Q3 Results Beat Expectations; Price Target Raised to C$2.75
Roth MKM Reiterates Buy on High Tide, Maintains $4.5 Price Target
High Tide Analyst Ratings
Echelon Wealth Partners Reaffirms Their Buy Rating on High Tide (HITI)
Stifel Initiates Coverage On High Tide With Buy Rating, Announces Price Target of C$2.5
High Tide Analyst Ratings
Analysts Conflicted on These NA Names: High Tide (HITI) and Frontdoor (FTDR)
Analysts Offer Insights on NA Companies: Mister Spex SE (DE:MRX) and High Tide (HITI)
No Data
No Data